Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Angiodynamics Inc Lowers FY 2013 Guidance

Monday, 8 Apr 2013 04:00pm EDT 

Angiodynamics Inc announced that for fiscal 2013, it expects sales to be between $337 million - $341 million, EBITDA to be between $50 million - $52 million and EPS to be between $0.32 - $0.35. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $341 million, EBITDA of $52 million and EPS of $0.33 for fiscal 2013. 

Company Quote

-0.35 -1.96%
1:00pm EST